Literature DB >> 28643496

WHIM Syndrome With a Novel CXCR4 Variant in a Korean Child.

Dong Woo Shin1, Si Nae Park2, Sung Min Kim2, Kyongok Im2, Jung Ah Kim1, Kyung Taek Hong2,3, Jung Yoon Choi2,3, Che Ry Hong2,3, Kyung Duk Park2,3, Hee Young Shin2,3, Hyoung Jin Kang2,3, Hyun Kyung Kim1,2, Dong Soon Lee1,4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28643496      PMCID: PMC5500746          DOI: 10.3343/alm.2017.37.5.446

Source DB:  PubMed          Journal:  Ann Lab Med        ISSN: 2234-3806            Impact factor:   3.464


× No keyword cloud information.
Dear Editor, Warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) syndrome is a rare, autosomal dominant, primary immunodeficiency disorder [1], with only 65 cases reported worldwide [2]. This disorder is caused by a gain-of-function mutation in CXCR4, which, along with its ligand CXCL12 (stromal cell-derived factor 1 [SDF-1]), plays a role in retention of mature neutrophils in the bone marrow (BM) [3]. Here we describe a Korean child with WHIM syndrome who had a novel CXCR4 mutation. To the best of our knowledge, this is the first report of WHIM syndrome in Korea. A Korean male was born at full term (3.9 kg) without perinatal problems. There was no family history of susceptibility to infection or neutropenia. At one month of age, he was brought to the Department of Plastic Surgery for correction of cleft lip, and complete blood count (CBC) revealed white blood cell counts of 2.09 ×109/L (absolute neutrophil count [ANC] 0/L), hemoglobin 99 g/L, and platelets 313×109/L. Differential count showed 98% lymphocytes and 2% monocytes, with absence of neutrophils on the peripheral blood smear. The surgery was postponed, and he was referred to a pediatric hematology specialist. At one year and five months of age, he visited the emergency department because of a right inguinal hernia; ANC was 0.06×109/L, and the surgery was performed successfully after administration of granulocyte-colony stimulating factor (G-CSF) (Fig. 1). At one year and eight months of age, BM examination showed a hypercellular BM with mild granulocytic hyperplasia (myeloid:erythroid ratio, 7:1) and right-shifted maturation. He was hospitalized for pneumonia and acute gastroenteritis at two years and six months of age. At two years and eight months of age, BM re-examination revealed plentiful granulopoietic cells with right-shifted maturation, and neutrophils showed characteristics of dysplasia such as pyknotic lobes with long filaments. Multifocal collections of mature neutrophils (myelokathexis) were observed in a BM section (Fig. 2A-I). The IgG level was decreased to 2.82 g/L (reference range: 7.0–17.0 g/L), IgA level was 0.19 g/L (0.9–4.0 g/L), and IgM level was 0.59 g/L (0.45–2.3 g/L), but warts were absent. Sanger sequencing of CXCR4 from BM aspirates revealed the novel sequence variant c.966_967delAG (p.Gly323Valfs*20) (Fig. 2J). Although he had no definite warts, the collective evidence of hypogammaglobulinemia, myelokathexis, multiple histories of infections, and CXCR4 mutation confirmed the diagnosis of WHIM syndrome.
Fig. 1

WBC and ANC results according to the patient's age and clinical events.

Abbreviations: CBC, complete blood count; WBC, white blood cell; ANC, absolute neutrophil count; G-CSF, granulocyte colony stimulating factor; BM, bone marrow; y, year(s); m, month(s).

Fig. 2

Results of bone marrow examination and Sanger sequencing of the CXCR4 gene. (A–F) Neutrophils with pyknotic nuclei, lobes separated by long strands of chromatin, and cytoplasmic vacuoles were observed (Wright Giemsa stain, ×1,000); (G) Marrow with hypercellularity and multifocal collections of mature neutrophils were observed (hematoxylin and eosin stain, ×200); (H) Anti-CXCR4 immunohistochemical stain showed an absence of CXCR4 surface protein; (I) A mouse spleen section was stained as a positive control for anti-CXCR4 stain (×400; Ab1670, Abcam, Cambridge, UK); (J) Chromatogram was obtained from Sanger sequencing of the CXCR4 gene (reference sequence: NM_003467.2). Reverse sequence reading from the 3′ end revealed the c.966_967delAG frameshift variant. Designation was based on the 3′ rule that the most 3′ position possible of the reference sequence is arbitrarily assigned to have been changed.

Congenital neutropenia involving mutation of ELANE, CSF3R, WAS, and HAX1 is characterized by maturation arrest of granulocytic-series cells [4]. In contrast to maturation arrest, CXCR4 mutation causes retention of mature neutrophils in the BM, resulting in peripheral neutropenia. The fate of retained neutrophils due to enhanced CXCR4 activity delays the release of mature neutrophils from the BM, resulting in neutropenia and senescence with apoptosis of mature neutrophils retained in the BM [5]. Since CXCR4 signaling also regulates the expression of CD20 on B cells, consequential hypogammaglobulinemia develops in WHIM [6]. The variant found in this case, c.966_967delAG (p.Gly323Valfs *20), is a novel pathogenic variant. The most common CXCR4 mutation among WHIM syndrome patients is p.Arg334*, and other reported mutations are p.Gly336*, p.Ser338*, p.Glu343*, p.Ser339fs, p.Lys329fs, and p.Ser324fs (the mutation most similar to that in our case) [37]. CXCR4 has an extracellular N-terminus encoding transmembrane helices, and a C-terminus encoding the cytoplasmic portion. The disulfide bond in the N-terminus is essential for CXCL12 binding, and G-CSF induces cleavage of the N-terminus of CXCR4 on hematopoietic stem cells, reducing the retention of hematopoietic cells in the BM [8]. All of the CXCR4 mutations associated with WHIM syndrome reside in the C-terminus, resulting in truncation of the C-terminal domain of the protein, with persistent CXCR4 activation and BM myeloid cell trafficking [1]. Immunohistochemical staining of a BM section with anti-CXCR4 antibody showed absence of CXCR4 surface protein owing to truncation of the CXCR4 C-terminal proportion in this patient (Fig. 2H). Somatic mutations in CXCR4 were identified in 30% of Waldenström macroglobulinemia (WM) patients, in whom the locations of somatic mutations are similar to those in WHIM syndrome [9]. Although the most well-known cause of WHIM syndrome is CXCR4 mutation, WHIM patients without CXCR4 mutation showing hyperresponsiveness to CXCL12 have been reported [10]. Among the 37 WHIM syndrome patients, the frequency of warts, hypogammaglobulinemia, and neutropenia as a first presentation was 78.6%, 89.6%, and 91.7%, respectively [3]. Considering that patients with WHIM syndrome typically present numerous warts on the hands, feet, and trunk, with variable age at diagnosis, the current patient is atypical in that he had no warts and the initial BM features showed no apparent dysplastic neutrophils and myelokathexis. More to the point, these atypical features can lead to missing the diagnosis. In this case, we performed the follow-up BM examination and CXCR4 sequencing and finally diagnosed a WHIM syndrome with a novel CXCR4 mutation. To avoid missing the diagnosis, suspicion of WHIM is important and follow-up BM examination should be considered.
  9 in total

1.  The genomic landscape of Waldenstrom macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis.

Authors:  Zachary R Hunter; Lian Xu; Guang Yang; Yangsheng Zhou; Xia Liu; Yang Cao; Robert J Manning; Christina Tripsas; Christopher J Patterson; Patricia Sheehy; Steven P Treon
Journal:  Blood       Date:  2013-12-23       Impact factor: 22.113

Review 2.  CXCR4 signaling in health and disease.

Authors:  Tommaso Pozzobon; Giacomo Goldoni; Antonella Viola; Barbara Molon
Journal:  Immunol Lett       Date:  2016-06-27       Impact factor: 3.685

3.  Ibrutinib inhibits CD20 upregulation on CLL B cells mediated by the CXCR4/SDF-1 axis.

Authors:  Gabriela Pavlasova; Marek Borsky; Vaclav Seda; Katerina Cerna; Jitka Osickova; Michael Doubek; Jiri Mayer; Raffaele Calogero; Martin Trbusek; Sarka Pospisilova; Matthew S Davids; Thomas J Kipps; Jennifer R Brown; Marek Mraz
Journal:  Blood       Date:  2016-08-01       Impact factor: 22.113

4.  MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment.

Authors:  Jürgen Bernhagen; Regina Krohn; Hongqi Lue; Julia L Gregory; Alma Zernecke; Rory R Koenen; Manfred Dewor; Ivan Georgiev; Andreas Schober; Lin Leng; Teake Kooistra; Günter Fingerle-Rowson; Pietro Ghezzi; Robert Kleemann; Shaun R McColl; Richard Bucala; Michael J Hickey; Christian Weber
Journal:  Nat Med       Date:  2007-04-15       Impact factor: 53.440

5.  WHIM syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12.

Authors:  Karl Balabanian; Bernard Lagane; José Luis Pablos; Lysiane Laurent; Thierry Planchenault; Olivier Verola; Celeste Lebbe; Delphine Kerob; Alain Dupuy; Olivier Hermine; Jean-François Nicolas; Véronique Latger-Cannard; Danièle Bensoussan; Pierre Bordigoni; Françoise Baleux; Françoise Le Deist; Jean-Louis Virelizier; Fernando Arenzana-Seisdedos; Françoise Bachelerie
Journal:  Blood       Date:  2004-11-09       Impact factor: 22.113

Review 6.  Congenital neutropenia: diagnosis, molecular bases and patient management.

Authors:  Jean Donadieu; Odile Fenneteau; Blandine Beaupain; Nizar Mahlaoui; Christine Bellanné Chantelot
Journal:  Orphanet J Rare Dis       Date:  2011-05-19       Impact factor: 4.123

Review 7.  WHIM syndrome: congenital immune deficiency disease.

Authors:  Toshinao Kawai; Harry L Malech
Journal:  Curr Opin Hematol       Date:  2009-01       Impact factor: 3.284

8.  Description and outcome of a cohort of 8 patients with WHIM syndrome from the French Severe Chronic Neutropenia Registry.

Authors:  Sarah Beaussant Cohen; Odile Fenneteau; Emmanuel Plouvier; Pierre-Simon Rohrlich; Gerard Daltroff; Isabelle Plantier; Alain Dupuy; Delphine Kerob; Blandine Beaupain; Pierre Bordigoni; Fanny Fouyssac; Anne-Lise Delezoide; Gilles Devouassoux; Jean François Nicolas; Philippe Bensaid; Yves Bertrand; Karl Balabanian; Christine Bellanne Chantelot; Françoise Bachelerie; Jean Donadieu
Journal:  Orphanet J Rare Dis       Date:  2012-09-25       Impact factor: 4.123

Review 9.  Diversity and Inter-Connections in the CXCR4 Chemokine Receptor/Ligand Family: Molecular Perspectives.

Authors:  Lukas Pawig; Christina Klasen; Christian Weber; Jürgen Bernhagen; Heidi Noels
Journal:  Front Immunol       Date:  2015-08-21       Impact factor: 7.561

  9 in total
  3 in total

Review 1.  WHIM Syndrome: from Pathogenesis Towards Personalized Medicine and Cure.

Authors:  Lauren E Heusinkveld; Shamik Majumdar; Ji-Liang Gao; David H McDermott; Philip M Murphy
Journal:  J Clin Immunol       Date:  2019-07-16       Impact factor: 8.317

2.  Case Report: A Novel CXCR4 Mutation in a Chinese Child With Kawasaki Disease Causing WHIM Syndrome.

Authors:  Xiaopeng Ma; Yaping Wang; Peng Wu; Meiyun Kang; Yue Hong; Yao Xue; Chuqin Chen; Huimin Li; Yongjun Fang
Journal:  Front Immunol       Date:  2022-04-13       Impact factor: 8.786

3.  Heterogeneous genetic landscape of congenital neutropenia in Korean patients revealed by whole exome sequencing: genetic, phenotypic and histologic correlations.

Authors:  Dajeong Jeong; Sung-Min Kim; Byung Joo Min; Ju Han Kim; Young Seok Ju; Yong-Oon Ahn; Jiwon Yun; Young Eun Lee; Seok Ryun Kwon; Jae Hyeon Park; Jong Hyun Yoon; Dong Soon Lee
Journal:  Sci Rep       Date:  2022-05-07       Impact factor: 4.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.